U.S. Markets closed

Celgene Corporation (CELG)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
133.85-0.46 (-0.34%)
At close: 4:00PM EDT

133.99 0.14 (0.10%)
After hours: 6:51PM EDT

People also watch
Full screen
Previous Close134.31
Bid133.50 x 200
Ask134.20 x 200
Day's Range132.56 - 134.44
52 Week Range94.42 - 135.18
Avg. Volume3,817,863
Market Cap104.51B
PE Ratio (TTM)50.26
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Biotech Stock With 497% Growth, Positive Trial Results Nears Buy Zone
    Investor's Business Daily3 hours ago

    Biotech Stock With 497% Growth, Positive Trial Results Nears Buy Zone

    With biotech stocks like Celgene, Bluebird Bio and Regeneron on the move, cancer treatment developer Exelixis may be poised to pop into a new buy zone.

  • Barrons.com4 hours ago

    Seattle Genetics: A Disappointing Study…Or Was It?

    Shares of Seattle Genetics (SGEN) are moving lower today, falling more than 9% after the drug maker’s experimental lymphoma drug failed to impress. The data from the late-stage study testing Adcetris, co-developed with Japan's Takeda Pharmaceutical, helped blood cancer patients live longer without worsening their conditions, meeting its endpoint. Altogether, lots of uncertainty whether these data could support a robust commercial adoption.

  • 24/7 Wall St.8 hours ago

    Agio Pharma Sinks on Midstage Trial

    Agio Pharmaceuticals saw its shares sink on Monday after the firm announced results from its midstage trial for the treatment of relapsed or refractory acute myeloid leukemia.